Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers

Mostrar otras versiones (1)

Accurate serological assays to detect antibodies to SARS-CoV-2 are needed to characterize the epidemiology of SARS-CoV-2 infection and identify potential candidates for COVID-19 convalescent plasma (CCP) donation. This study compared the performance of commercial enzyme immunoassays (EIAs) to detect...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Eshan U., Bloch, Evan M., Clarke, William, Hsieh, Yu-Hsiang, Boon, Denali, Eby, Yolanda, Fernandez, Reinaldo E., Baker, Owen R., Keruly, Morgan, Kirby, Charles S., Klock, Ethan, Littlefield, Kirsten, Miller, Jernelle, Schmidt, Haley A., Sullivan, Philip, Piwowar-Manning, Estelle, Shrestha, Ruchee, Redd, Andrew D., Rothman, Richard E., Sullivan, David, Shoham, Shmuel, Casadevall, Arturo, Quinn, Thomas C., Pekosz, Andrew, Tobian, Aaron A.R., Laeyendecker, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480035/
https://www.ncbi.nlm.nih.gov/pubmed/32908987
http://dx.doi.org/10.1101/2020.08.31.20184788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480035/
https://www.ncbi.nlm.nih.gov/pubmed/32908987
http://dx.doi.org/10.1101/2020.08.31.20184788

Ejemplares similares